Core Viewpoint - TATA Health (01255) reported a significant increase in revenue for the fiscal year 2023, but also faced a substantial loss attributed to ongoing challenges in its healthcare and online medical services business [1] Financial Performance - Revenue for the year was approximately HKD 207.5 million, representing a year-on-year increase of about 43.5% [1] - The company reported a loss attributable to shareholders of HKD 32.29 million, marking a shift from profit to loss compared to the previous year [1] - Earnings per share were reported at a loss of HKD 0.13 [1] Business Challenges - The losses were primarily due to the healthcare and online medical services segment, which continues to operate at a long-term loss and is currently in a state of operational stagnation [1]